+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2025-2030- Product Image
Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2025-2030- Product Image
Sale

Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120860
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Molecular diagnostics for colorectal cancer are experiencing a period of transformation, empowering healthcare organizations to enhance early detection, treatment precision, and care outcomes. Advances in genome technology, bioinformatics, and collaborative partnerships are shaping this market as adoption accelerates among diverse clinical environments.

Market Snapshot: Colorectal Cancer Molecular Diagnostics

The colorectal cancer molecular diagnostics market is propelled by rapid innovation in next-generation sequencing, digital PCR, and advanced bioinformatics. Widespread adoption of noninvasive liquid biopsy and integration of companion diagnostics into patient pathways are reinforcing its vital role in modern oncology. Industry leaders are driving product pipelines, while strategic alliances and cloud-native analytics support scalable operations across diagnostic labs, reference centers, and hospitals. These factors underpin a robust growth trajectory, with the segment advancing toward broader clinical accessibility and streamlined diagnostics.

Scope & Segmentation

This report comprehensively maps the evolving molecular diagnostics landscape, offering in-depth analysis by technology, application, biomarker, sample type, product, and end user. Regional nuances in supply-chain management, reimbursement, and adoption are also explored.

  • Technologies: Fluorescence in situ hybridization, microarray, next-generation sequencing (targeted, whole exome, whole genome), polymerase chain reaction (digital, quantitative)
  • Product Types: PCR systems, sequencers, kits, reagents, bioinformatics services, data analysis software
  • Applications: Companion diagnostics, predictive testing, prognostic testing, residual disease monitoring
  • Biomarkers: BRAF, KRAS, microsatellite instability, NRAS
  • Sample Types: Blood (plasma, serum), stool, tissue
  • End Users: Academic institutes, hospital clinics, diagnostic centers, reference laboratories
  • Regions: Americas (U.S., Canada, Latin America), Europe, Middle East, Africa, Asia-Pacific

Segment relevance is illustrated by the interplay between advanced sequencing and informatics, enabling targeted therapy and real-world patient management. Rapid uptake in emerging markets is driven by local partnerships and expanded laboratory infrastructures.

Key Takeaways for Decision-Makers

  • Strategic collaborations across manufacturers, reagent suppliers, and clinical labs are expediting product innovation and streamlining regulatory pathways.
  • Advances in digital PCR and next-generation sequencing provide absolute nucleic acid quantification, supporting early mutation detection and accurate monitoring of minimal residual disease.
  • The integration of machine learning in data analysis software accelerates actionable genomic insights, benefiting both diagnostic centers and research organizations.
  • Noninvasive approaches, including liquid biopsy from blood derivatives, expand clinical utility and patient access to precision testing.
  • Regional market differences influence technology adoption rates, regulatory approval timelines, and resilience strategies for supply-chain management.

Tariff Impact: Assessing Supply Chain and Accessibility

The 2025 United States tariffs have increased costs for molecular diagnostics instruments, kits, and reagents needed for colorectal cancer testing. Resulting supply-chain pressures have prompted healthcare providers and distributors to pursue alternate sourcing, regional stockpiling, and intensified supplier negotiations. While domestic manufacturing is advancing, near-term capacity for high-precision platforms remains limited, underscoring the need for adaptable procurement strategies. Diagnostic protocols now prioritize essential applications, with some sample analysis shifted to reference labs to mitigate disruption.

Methodology & Data Sources

This report leverages primary interviews with industry specialists, laboratory directors, and leading executives, supported by rigorous review of regulatory filings, journal publications, and patent data. Quantitative modeling and supply chain scenario planning further validate adoption trends, ensuring robust and actionable insights throughout.

Why This Report Matters

  • Delivers targeted, segment-level insights to guide technology investment, partnership strategy, and portfolio expansion within colorectal cancer molecular diagnostics.
  • Clarifies regional market differences, supporting geographic entry, product localization, and supply-chain optimization.

Competitive Landscape and Strategic Partnerships

Leading industry players, including F. Hoffmann-La Roche Ltd, Illumina, Thermo Fisher Scientific, and Qiagen N.V., are accelerating innovation through cross-sector alliances and R&D investments. Expansion into high-throughput sequencing, integration of bioinformatics, and modular platform development are central to maintaining differentiation. New entrants specializing in artificial intelligence-driven analytics continue to fill bioinformatics and workflow gaps, further enriching the ecosystem. Strategic licensing and co-development initiatives promote harmonized solutions across both mature and emerging markets.

Conclusion

The colorectal cancer molecular diagnostics market is driven by cutting-edge genome technologies, collaborative innovation, and increasingly sophisticated data analysis. Organizations aligned with regulatory evolution and supply chain resilience will effectively advance patient care through precision oncology solutions.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of next-generation sequencing panels for personalized colorectal cancer treatment selection
5.2. Development of liquid biopsy assays using circulating tumor DNA for early colorectal cancer detection
5.3. Growth of AI-driven molecular diagnostic platforms for accurate colorectal cancer risk stratification
5.4. Adoption of comprehensive multi-gene panel testing to identify actionable mutations in colorectal tumors for targeted therapy guidance
5.5. Expansion of companion diagnostic tests to guide targeted therapies in metastatic colorectal cancer treatment pathways
5.6. Emergence of DNA methylation-based assays offering improved specificity in colorectal cancer screening programs
5.7. Regulatory approval and reimbursement challenges influencing adoption of colorectal cancer molecular diagnostic tests
5.8. Implementation of non-invasive stool-based molecular screening tests for population-wide colorectal cancer detection
5.9. Advances in minimal residual disease monitoring techniques using circulating biomarkers to predict colorectal cancer recurrence risk
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Colorectal Cancer Molecular Diagnostics Market, by Technology
8.1. Introduction
8.2. Fluorescence in Situ Hybridization
8.3. Microarray
8.4. Next Generation Sequencing
8.4.1. Targeted Sequencing
8.4.2. Whole Exome Sequencing
8.4.3. Whole Genome Sequencing
8.5. Polymerase Chain Reaction
8.5.1. Digital PCR
8.5.2. Quantitative PCR
9. Colorectal Cancer Molecular Diagnostics Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. PCR Systems
9.2.2. Sequencers
9.3. Kits Reagents
9.4. Software Services
9.4.1. Bioinformatics Services
9.4.2. Data Analysis Software
10. Colorectal Cancer Molecular Diagnostics Market, by Application
10.1. Introduction
10.2. Companion Diagnostics
10.3. Predictive Testing
10.4. Prognostic Testing
10.5. Residual Disease Monitoring
11. Colorectal Cancer Molecular Diagnostics Market, by Biomarker
11.1. Introduction
11.2. BRAF
11.3. KRAS
11.4. Microsatellite Instability
11.5. NRAS
12. Colorectal Cancer Molecular Diagnostics Market, by Sample Type
12.1. Introduction
12.2. Blood
12.2.1. Plasma
12.2.2. Serum
12.3. Stool
12.4. Tissue
13. Colorectal Cancer Molecular Diagnostics Market, by End User
13.1. Introduction
13.2. Academic Research Institutes
13.3. Diagnostic Centers
13.4. Hospitals Clinics
13.5. Reference Laboratories
14. Americas Colorectal Cancer Molecular Diagnostics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Colorectal Cancer Molecular Diagnostics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd
17.3.2. Illumina, Inc.
17.3.3. Thermo Fisher Scientific Inc.
17.3.4. Qiagen N.V.
17.3.5. Hologic, Inc.
17.3.6. Exact Sciences Corporation
17.3.7. Guardant Health, Inc.
17.3.8. Sysmex Corporation
17.3.9. Bio-Rad Laboratories, Inc.
17.3.10. Agilent Technologies, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 28. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 29. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 30. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PROGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PROGNOSTIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESIDUAL DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESIDUAL DISEASE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BRAF, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BRAF, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KRAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY KRAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROSATELLITE INSTABILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROSATELLITE INSTABILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NRAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NRAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 145. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 148. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 149. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 150. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 151. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 154. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 155. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 156. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 157. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 160. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 161. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 164. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 165. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 170. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 171. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 178. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 179. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 186. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 187. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE SERVICES, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM COLORECTAL CANCER MOLEC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Colorectal Cancer Molecular Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Hologic, Inc.
  • Exact Sciences Corporation
  • Guardant Health, Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.

Related Topics

Related Reports

Colorectal Cancer Test Kit Market - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Test Kit Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Market Report 2025 - Product Image

Colorectal Cancer Molecular Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030 - Product Image

Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030

  • Report
  • 540 Pages
  • Global
From
Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2025-2033 - Product Image

Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.